Tyler Lunow-Luke

Tyler Lunow-Luke

Auto-generated profile, based on publicly available information

Tyler Lunow-Luke

Department of Surgery, School of Medicine, University of California Irvine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2025 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
JKJae-Jun Kim
Jae-Jun Kim
SKSimone N. T. Kurial
Simone N. T. Kurial
PCPervinder K. Choksi
Pervinder K. Choksi
MNMiguel Nunez
Miguel Nunez
TLTyler Lunow-Luke
Tyler Lunow-Luke
HWHolger Willenbring
Holger Willenbring
Therapeutic efficacy and safety of adeno-associated virus (AAV) liver gene therapy depend on capsid choice. To predict AAV capsid performance under near-clinical conditions, we established side-by-side comparison at single-cell resolution in human livers maintained by normothermic machine perfusion. AAV-LK03 transduced hepatocytes much more efficiently and specifically than AAV5, AAV8 and AAV6, which are most commonly used clinically, and AAV-NP59, which is better at transducing human hepatocytes engrafted in immune-deficient mice. AAV-LK03 preferentially transduced periportal hepatocytes in normal liver, whereas AAV5 targeted pericentral hepatocytes in steatotic liver. AAV5 and AAV8 transduced liver sinusoidal endothelial cells as efficiently as hepatocytes. AAV capsid and steatosis influenced vector episome formation, which determines gene therapy durability, with AAV5 delaying concatemerization. Our findings inform capsid choice in clinical AAV liver gene therapy, including consideration of disease-relevant hepatocyte zonation and effects of steatosis, and facilitate the development of AAV capsids that transduce hepatocytes or other therapeutically relevant cell types in the human liver with maximum efficiency and specificity.

23 February 2023 in Human Immunology
Verified
Journal Article
Closed access
GRGarrett R. Roll
Garrett R. Roll
RBRobert A. Bray
Robert A. Bray
MCMatthew Cooper
Matthew Cooper
TETodd N. Eagar
Todd N. Eagar
HGHoward M. Gebel
Howard M. Gebel
RRRaja Rajalingam
Raja Rajalingam

1 August 2026 in Medical Education Online
Verified
Journal Article
Open access
CACorine Astroth
Corine Astroth
TLTyler Lunow-Luke
Tyler Lunow-Luke
MSMaren Smith
Maren Smith
JCJosephine Chang
Josephine Chang
AGAreg Grigorian
Areg Grigorian
MOMichael P. O’LEary
Michael P. O’LEary
Following the change in 2022 of a scored United States Medical Licensing Examination (USMLE) Step 1 to a binary pass-fail grading system, greater emphasis has been placed on the Step 2 Clinical Knowledge (Step 2 CK) exam. Shelf or subject exams offered by the National Board of Medical Examiners (NBME) help prepare students for Step 2CK and therefore deserve the attention of clerkship directors. This paper reviews the literature pertaining to the factors that positively and negatively impact medical students' performance on the shelf exams, including but not limited to performance in the pre-clinical years, clinical exposures, peer learning, active or team-based learning, length of clerkships, and order and number of previous shelf exams. The PubMed database was searched to identify studies describing factors influencing performance on shelf exam scores during medical school and strategies for improving shelf scores. Studies were identified through iterative searches using multiple keyword combinations related to NBME shelf examinations, NBME subject examinations, clerkship performance, academic achievement, and educational interventions. Inclusion criteria consisted of English-language studies published between 2005 and 2025 involving students at U.S. allopathic or osteopathic medical schools. The included studies were reviewed for relevance and methodological rigour, including consideration of study design, sample size, statistical analyses, and reported outcomes. A robust pre-clinical education remains vital for success on NBME shelf examinations. Exam scores are also influenced by the number and order of previous exams. Increased clinical exposure, active learning, team-based approaches, and peer review sessions have not consistently shown improvements in performance. This review underscores the importance of a foundational understanding of the basic sciences for student success on exams, while acknowledging that clerkship directors must balance their obligation to adequately prepare students for standardized testing with their mission to craft compassionate and competent future clinicians.

1 March 2026 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
TLTyler Lunow-Luke
Tyler Lunow-Luke
JCJosephine E. Chang
Josephine E. Chang
RPRobert Painter
Robert Painter
CLCarlin Lee
Carlin Lee
RNRonak Naik
Ronak Naik
HKHari Balaji Keshava
Hari Balaji Keshava
Background and Objective: Current protocols lack validated non-destructive modalities to intraoperatively evaluate lung tissue without excision and histological processing, a critical step for confirming negative margins during cancer resections. Surgeons currently rely on preoperative radiologic imaging and intraoperative tactile feedback. Consequently, there is a persistent need to improve intraoperative identification and visualization of lung pathologies, including nodules, ground-glass opacities, and their margins relative to healthy parenchyma. Optical imaging modalities have emerged as promising tools for intraoperative lung visualization. While molecular imaging approaches have been extensively reviewed, non-molecular intraoperative optical modalities remain comparatively underrepresented. This narrative review summarizes recent clinical developments in non-molecular optical imaging of lung tissue and compares them with contrast-dependent approaches. Inclusion and exclusion criteria focused the scope on primary literature reporting intraoperative optical imaging of lung parenchyma or bronchial tissues between 2008 and 2025. Imaging modalities were evaluated based on their ability to visualize lung tissue and discriminate healthy from abnormal regions. Methods: . Key Content and Findings: Molecular imaging techniques included indocyanine green (ICG)-based imaging, with and without targeted probes, as well as confocal laser endomicroscopy (CLE). Exogenous contrast-dependent modalities demonstrate efficacy in lung surgery, enabling identification of nodules and intersegmental planes. However, these approaches are limited by contrast spillover into the operative field, dye-associated adverse reactions, narrow imaging time windows, and reliance on surrogate biomarkers that provide limited quantitative information. In contrast, non-molecular imaging modalities operate independently of exogenous agents and directly measure intrinsic optical properties of tissue. Their limitations include shallow tissue penetrance and challenges associated with analyzing large spectral data sets. Machine learning (ML) techniques may enhance both molecular and non-molecular imaging by improving image processing, enabling data integration, and supporting complementary multimodal imaging strategies. Conclusions: Non-molecular intraoperative imaging modalities are clinically feasible and safe. They enable differentiation of pathological and normal lung tissue while assessing physiologic properties without contrast agents, thereby avoiding spill-over and time constraints. These technologies offer to enhance intraoperative visualization beyond preoperative imaging and tactile assessment. With refinement and validation, non-molecular optical imaging may reduce dependence on histopathology, improve intraoperative decision-making, and enhance surgical outcomes.